Br. Brooks et al., Functional magnetic resonance imaging (fMRI) clinical studies in ALS - paradigms, problems and promises, AMYOTROPH L, 1, 2000, pp. S23-S32
Citations number
72
Categorie Soggetti
Neurology
Journal title
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
Functional magnetic resonance imaging (fMRI) provides high-resolution, non-
invasive estimates of neural activity detected by a blood oxygen level depe
ndant signal by assessing the increase in blood flow to the local vasculatu
re that accompanies neural activity in the brain, fMRI studies with standar
d hand motor test (index-thumb opposition, ITO, or pinch) in ALS patients s
how good test-retest reliability and similar amplitude of signals in ALS pa
tients compared with control subjects. Isometric force can be performed wit
h careful control for the force exerted, recruitment of other muscles and m
otion artefact. The volume (number of voxels above threshold) of sensorimot
or and cerebellar cortex activated by ITO is reproducibly larger in ALS pat
ients compared with control subjects. Imagined movements in ALS have been s
tudied, as in amputees, and larger volumes are activated in ALS patients wi
th imagined movements as well, compared with control subjects. fMRI studies
in ALS patients evaluating cortical activation during pure somatosensory s
timulation cutaneous stimulation of the hand to elicit the palmomental resp
onse and cutaneous stimulation of the sole to elicit the plantar response -
indicate that ALS patients activate a significantly smaller volume of the
contralateral sensorimotor cortex compared to control subjects. No statisti
cally significant difference was seen in other areas, including the ipsilat
eral cerebellum and the contralateral thalamus. An anterior shift in the vo
lume of cortex activated by these paradigms occurs in ALS patients, with a
volume of activation, anteriorly, not activated in control subjects. fMRI s
tudies will complement other clinical neurophysiological and neuroimaging t
echniques in our future attempts to solve the riddle of ALS and other motor
neuron diseases.